Article info
PDFSection 5: Patient Safety and Quality assurance
5PSQ-062 Effectiveness of adalimumab in inflammatory bowel disease and influence of response to firstline treatment
Citation
5PSQ-062 Effectiveness of adalimumab in inflammatory bowel disease and influence of response to firstline treatment
Publication history
- First published March 24, 2020.
Online issue publication
August 05, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.